Integer Holdings Corporation
ITGR
주식 순위
#3855
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
주가
$126.70
마지막 동기화: 2026-10-16
시가총액
$4.31B
변동 (1일)
-0.02%
변동 (1년)
20.86%
국가
US
거래 Integer Holdings Corporation (ITGR)
카테고리
Healthcare
Integer Holdings Corporation (ITGR)의 영업이익률
October 2026 기준 영업이익률 TTM: 9.47%
Integer Holdings Corporation의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 9.47%입니다. 2023년 말 기준 영업이익률은 10.48%였습니다.
Integer Holdings Corporation의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 9.47% | -21.93% |
| 2024 | 12.13% | 15.74% |
| 2023 | 10.48% | 18.82% |
| 2022 | 8.82% | -20.61% |
| 2021 | 11.11% | -1.16% |
| 2020 | 11.24% | -10.30% |
| 2019 | 12.53% | -2.11% |
| 2018 | 12.80% | 34.17% |
| 2017 | 9.54% | 22.15% |
| 2016 | 7.81% | -29.00% |
| 2015 | 11.00% | 19.05% |
| 2014 | 9.24% | 131.00% |
| 2012 | 4.00% | -63.13% |
| 2011 | 10.85% | -16.09% |
| 2010 | 12.93% | 102.66% |
| 2009 | 6.38% | 1.59% |
| 2007 | 6.28% | -23.88% |
| 2006 | 8.25% | 17.86% |
| 2005 | 7.00% | -47.99% |
| 2004 | 13.46% | -15.56% |
| 2003 | 15.94% | -3.45% |
| 2001 | 16.51% | 12.08% |
| 2000 | 14.73% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 17.03% | -98.20% |
US
|
|
| 17.86% | -98.11% |
IE
|
|
| 22.03% | -97.67% |
US
|
|
| 21.46% | -97.73% |
US
|
|
| 0.00% | - |
DE
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.